These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 14732372)

  • 1. Diagnosis and misdiagnosis of hemifacial spasm: a clinical and video study.
    Tan NC; Tan EK; Khin LW
    J Clin Neurosci; 2004 Feb; 11(2):142-4. PubMed ID: 14732372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Babinski-2 sign in hemifacial spasm.
    Pawlowski M; Gess B; Evers S
    Mov Disord; 2013 Aug; 28(9):1298-300. PubMed ID: 23637014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin improves quality of life in hemifacial spasm: validation of a questionnaire (HFS-30).
    Tan EK; Fook-Chong S; Lum SY; Lim E
    J Neurol Sci; 2004 Apr; 219(1-2):151-5. PubMed ID: 15050451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy of Hemifacial Spasm with Botulinum Toxin].
    Jost WH; Laskawi R; Palmowski-Wolfe A; Urban PP
    Fortschr Neurol Psychiatr; 2017 Apr; 85(4):194-198. PubMed ID: 28437820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin therapy of hemifacial spasm: comparing different therapeutic preparations.
    Frei K; Truong DD; Dressler D
    Eur J Neurol; 2006 Feb; 13 Suppl 1():30-5. PubMed ID: 16417595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in improvement between patients with idiopathic versus neurovascular hemifacial spasm after botulinum toxin treatment.
    Tunç T; Cavdar L; Karadağ YS; Okuyucu E; Coşkun O; Inan LE
    J Clin Neurosci; 2008 Mar; 15(3):253-6. PubMed ID: 18191574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Causes for treatment delays in dystonia and hemifacial spasm: a Canadian survey.
    Jog M; Chouinard S; Hobson D; Grimes D; Chen R; Bhogal M; Simonyi S
    Can J Neurol Sci; 2011 Sep; 38(5):704-11. PubMed ID: 21856572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin type B (Myobloc) in subjects with hemifacial spasm: results from an open-label, dose-escalation safety study.
    Trosch RM; Adler CH; Pappert EJ
    Mov Disord; 2007 Jul; 22(9):1258-64. PubMed ID: 17588242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemifacial spasm and its treatment with botulinum toxin].
    Gouider-Khouja N; Turki I; Ben Hamida M; Hentati F
    Tunis Med; 1999 Jan; 77(1):41-4. PubMed ID: 10333697
    [No Abstract]   [Full Text] [Related]  

  • 10. Botulinum toxin in the treatment of blepharospasm and hemifacial spasm.
    Kenney C; Jankovic J
    J Neural Transm (Vienna); 2008; 115(4):585-91. PubMed ID: 17558461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin injections for the treatment of hemifacial spasm over 16 years.
    Sorgun MH; Yilmaz R; Akin YA; Mercan FN; Akbostanci MC
    J Clin Neurosci; 2015 Aug; 22(8):1319-25. PubMed ID: 26100157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Hemifacial Spasm Grading Scale: a clinical tool for hemifacial spasm.
    Tambasco N; Simoni S; Sacchini E; Eusebi P; Marsili E; Nigro P; Brahimi E; Paoletti FP; Romoli M; Calabresi P
    Neurol Sci; 2019 Sep; 40(9):1887-1892. PubMed ID: 31076941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of botulinum toxin-B (BTX-B) injections for hemifacial spasm.
    Tousi B; Perumal JS; Ahuja K; Ahmed A; Subramanian T
    Parkinsonism Relat Disord; 2004 Oct; 10(7):455-6. PubMed ID: 15465407
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemimasticatory spasm treated with botulinum toxin: case report.
    Teive HA; Piovesan EJ; Germiniani FM; Camargo CH; Sa D; Scola RH; Werneck LC
    Arq Neuropsiquiatr; 2002 Jun; 60(2-A):288-9. PubMed ID: 12068362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychogenic hemifacial spasm.
    Tan EK; Jankovic J
    J Neuropsychiatry Clin Neurosci; 2001; 13(3):380-4. PubMed ID: 11514645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The validation of the disease-specific questionnaire for health-related quality of life in Thai patients with hemifacial spasm.
    Setthawatcharawanich S; Aui-aree N; Limapichart K; Satirapunya P; Phabphal K
    J Med Assoc Thai; 2008 Nov; 91(11):1691-7. PubMed ID: 19127791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of stigmatization in hemifacial spasm and quality of life before and after botulinum toxin treatment.
    Yuksel B; Genc F; Yaman A; Goksu EO; Ak PD; Gomceli YB
    Acta Neurol Belg; 2019 Mar; 119(1):55-60. PubMed ID: 30178181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Misdiagnosis of hemifacial spasm is a frequent event in the primary care setting.
    Martinez AR; Nunes MB; Immich ND; Piovesana L; França M; Campos LS; D'Abreu A
    Arq Neuropsiquiatr; 2014 Feb; 72(2):119-22. PubMed ID: 24604365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemifacial spasm].
    Krystkowiak P
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S142-5. PubMed ID: 19576481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment outcome correlates with knowledge of disease in hemifacial spasm.
    Tan EK; Hameed S; Fook-Chong S; Hussein K; Lum SY; Chan LL
    Clin Neurol Neurosurg; 2008 Sep; 110(8):813-7. PubMed ID: 18583029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.